Market Trends– category –
-
Forbes Details Cedars-Sinai’s Wearable Data & EHR Integration: AI Leveraged to Alleviate Clinician Burden
Forbes USA Overview Forbes reports Cedars-Sinai Hospital has been integrating wearable biosensor data directly into Electronic Health Records (EHRs) for over a decade. The core challenge is developing clinical workflows where this data i... -
FDA Draft IVD Guide Reshapes 510(k) Planning for Portable POCT and Digitally Connected Diagnostic Devices
China Med Device, LLC USA Overview The U.S. FDA released a draft guidance on August 2, 2026, titled 'In Vitro Diagnostic Devices: Classification and Regulatory Pathways Guidance.' This document clarifies the classification and 510(k) sub... -
Dexcom Achieves 13% Q2 Revenue Growth as FDA Approves OTC Glucose Biosensor Stelo for Pediatric Use
Medical Design and Outsourcing USA Overview Dexcom reported a robust 13% year-over-year revenue growth in Q2 2026, demonstrating the efficacy of its CGM technology in non-insulin-using Type 2 diabetes patients. Concurrently, the U.S. FDA... -
Medtronic Launches Simplera Sync CGM Sensor in South Korea, Streamlining Glucose Management for MiniMed 780G Users
KBR South Korea Overview Medtronic has launched its Simplera Sync Sensor, a new continuous glucose monitoring (CGM) device, in South Korea for users of the MiniMed 780G automated insulin delivery (AID) system. This all-in-one disposable ... -
Compliance.ai Reports Over 11,000 New Regulatory Documents Added in Last 7 Days, With 50 Final Rules Taking Effect Soon
Compliance.ai USA Overview Compliance.ai announced the addition of 11,906 new proposed and final regulatory documents to its platform in the past seven days, reflecting a rapidly evolving regulatory landscape. The U.S. has recorded 1,558... -
U.S. NSF Fuels Regional Tech Hubs with $150M for Quantum, Bio, and Grid Modernization
Government News Release or University Announcement USA Overview The U.S. National Science Foundation (NSF) is investing $150 million in 12 new Regional Innovation Engines, initially providing $15 million over two years with potential exp... -
Canadian Government Designates Nanotechnology as R&D Priority, Offers Over 1500 Grant and Loan Programs
Canada.ca Canada Overview Canada's Business Benefits Finder lists over 1500 support programs, including grants, loans, and tax credits, with nanotechnology designated as a key research and development (R&D) focus area. These programs... -
China’s First Approved MSC Therapy, Ruibosheng, Launched at Fraction of Global Price, Receives Conditional Approval for Severe GVHD
BioInformant China Overview China's first approved mesenchymal stem cell (MSC) therapy, Ruibosheng, has been launched at a fraction of global pricing, having received conditional approval from the NMPA on January 2, 2025. Approved for st... -
Real-World Data Evaluates Incidence and Management of Cytokine Release Syndrome and Neurotoxicity Following Axicabtagene Ciloleucel or Brexucabtagene Autoleucel CAR-T Cell Therapy Across 87 U.S. Centers
PubMed (Center for International Blood and Marrow Transplant Research) USA Overview The Center for International Blood and Marrow Transplant Research (CIBMTR) conducted a real-world data analysis of 927 B-cell malignancy patients across ... -
ImmunoAct’s NexCAR19 Achieves 98% MRD Negativity in India with Significant Cost Reduction Compared to Western CAR-T Therapies
Citeline Scrip India Overview ImmunoAct's CAR-T cell therapy, NexCAR19 (talicabtagene autoleucel), achieved a 98% minimal residual disease (MRD) negativity rate in real-world Indian data, delivering comparable efficacy to Western CAR-T t...
